EFFECT OF COMBINED THERAPY WITH BEZAFIBRATE AND CHOLESTYRAMINE ON LOW-DENSITY LIPOPROTEIN METABOLISM IN TYPE-IIA HYPERCHOLESTEROLEMIA

被引：18

作者：

SERIES, JJ

CASLAKE, MJ

KILDAY, C

CRUICKSHANK, A

DEMANT, T

LORIMER, AR

PACKARD, CJ

SHEPHERD, J

机构：

[1] GLASGOW ROYAL INFIRM,DEPT PATHOL BIOCHEM,GLASGOW G4 0SF,SCOTLAND

[2] GLASGOW ROYAL INFIRM,DEPT MED CARDIOL,GLASGOW G4 0SF,SCOTLAND

来源：

METABOLISM-CLINICAL AND EXPERIMENTAL | 1989年 / 38卷 / 02期

关键词：

D O I：

10.1016/0026-0495(89)90255-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：153 / 158

页数：6

共 50 条

[1] IDENTIFICATION OF APOLIPOPROTEINS IN LIPOPROTEIN DENSITY CLASSES OF HYPERCHOLESTEROLEMIA (TYPE-IIA)
LEE, DM
[J]. FEBS LETTERS, 1975, 51 (01) : 116 - 120
[2] LONG-TERM EFFECTS OF BEZAFIBRATE AND OF A BEZAFIBRATE AND CHOLESTYRAMINE COMBINATION ON LIPIDS AND LIPOPROTEIN LIPIDS IN TYPE-IIA HYPERCHOLESTEROLEMIC PATIENTS
SOMMARIVA, D
TIRRITO, M
BONFIGLIOLI, D
POGLIAGHI, I
BRANCHI, A
CABRINI, E
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1986, 6 (03) : 249 - 253
[3] EFFECT OF CHOLESTYRAMINE ON LIPOPROTEIN LIPIDS IN PATIENTS WITH PRIMARY TYPE-IIA HYPERLIPOPROTEINEMIA
WEISWEILER, P
NEUREUTHER, G
SCHWANDT, P
[J]. ATHEROSCLEROSIS, 1979, 33 (03) : 295 - 300
[4] EFFECT OF SIMVASTATIN ON HIGH-DENSITY-LIPOPROTEIN SUBFRACTIONS AND APOLIPOPROTEINS IN TYPE-IIA HYPERCHOLESTEROLEMIA
CROOK, D
BRUCE, R
WORTHINGTON, M
MULCAHY, D
PATTERSON, D
WYNN, V
[J]. CARDIOVASCULAR DRUGS AND THERAPY, 1992, 6 (06) : 633 - 639
[5] CHANGE IN VERY LOW-DENSITY, LOW-DENSITY, AND HIGH-DENSITY-LIPOPROTEINS DURING LIPID LOWERING (BEZAFIBRATE) THERAPY - STUDIES IN TYPE-IIA AND TYPE-IIB HYPERLIPOPROTEINEMIA
GAVISH, D
OSCHRY, Y
FAINARU, M
EISENBERG, S
[J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1986, 16 (01) : 61 - 68
[6] THE EFFECT OF COMBINED FENOFIBRATE AND CHOLESTYRAMINE THERAPY ON LOW-DENSITY-LIPOPROTEIN KINETICS IN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS
MALMENDIER, CL
DELCROIX, C
LONTIE, JF
[J]. CLINICA CHIMICA ACTA, 1987, 162 (02) : 221 - 227
[7] KINETIC-STUDY OF THE LIPOPROTEIN METABOLISM HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (TYPE-IIA)
JAMES, RW
POMETTA, D
SHEPHERD, J
PACKARD, J
MARTIN, B
[J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, : 18 - 18
[8] EFFECT OF CHOLESTYRAMINE ON LOW-DENSITY LIPOPROTEIN - REPLY
SHEPHERD, J
PACKARD, CJ
BICKER, S
LAWRIE, TDV
MORGAN, HG
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (16): : 943 - 944
[9] LOW-DENSITY LIPOPROTEIN (LDL) METABOLISM AFTER CHOLESTYRAMINE AND ILEAL BYPASS IN FAMILIAL HYPERCHOLESTEROLEMIA (FH)
SPENGEL, F
SOUTAR, AK
DUFFIELD, R
WOOD, C
THOMPSON, GR
[J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1981, 11 (02) : 30 - 30
[10] CHOLESTYRAMINE TREATMENT OF TYPE-IIA HYPERCHOLESTEROLEMIA NORMALIZES PLATELET REACTIVITY AGAINST PROSTACYCLIN
LOBEL, P
STEINHAGENTHIESSEN, E
SCHROR, K
[J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1988, 18 (03) : 256 - 260

← 1 2 3 4 5 →